Advertisement

Citations to this article

Abstract

Mice deleted for the plasminogen activator inhibitor-1 (PAI-1) gene are relatively protected from developing pulmonary fibrosis induced by bleomycin. We hypothesized that PAI-1 deficiency reduces fibrosis by promoting plasminogen activation and accelerating the clearance of fibrin matrices that accumulate within the damaged lung. In support of this hypothesis, we found that the lungs of PAI-1–/– mice accumulated less fibrin after injury than wild-type mice, due in part to enhanced fibrinolytic activity. To further substantiate the importance of fibrin removal as the mechanism by which PAI-1 deficiency limited bleomycin-induced fibrosis, bleomycin was administered to mice deficient in the gene for the Aα-chain of fibrinogen (fib). Contrary to our expectation, fib–/– mice developed pulmonary fibrosis to a degree similar to fib+/– littermate controls, which have a plasma fibrinogen level that is 70% of that of wild-type mice. Although elimination of fibrin from the lung was not in itself protective, the beneficial effect of PAI-1 deficiency was still associated with proteolytic activity of the plasminogen activation system. In particular, inhibition of plasmin activation and/or activity by tranexamic acid reversed both the accelerated fibrin clearance and the protective effect of PAI-1 deficiency. We conclude that protection from fibrosis by PAI-1 deficiency is dependent upon increased proteolytic activity of the plasminogen activation system; however, complete removal of fibrin is not sufficient to protect the lung.

Authors

Noboru Hattori ... Richard H. Simon, Angela F. Drew

×

Total citations by year in Crossref

Year: 2013 2012 2011 2009 2008 2007 2006 2005 2004 2003 2002 2001 Total
Citations: 3 4 9 2 7 4 6 7 3 7 3 1 56
Citation information

Citations to this article in Crossref (56)

Title and authors Publication Year
Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs)
Y Cai, L Zhu, F Zhang, G Niu, S Lee, S Kimura, X Chen
Molecular Pharmaceutics 2013
Coagulation and coagulation signalling in fibrosis
PF Mercer, RC Chambers
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013
Plasminogen activator inhibitor-1 inhibitors: a patent review (2006 – present)
YM Fortenberry
Expert Opinion on Therapeutic Patents 2013
Role of the Lysophospholipid Mediators Lysophosphatidic Acid and Sphingosine 1-Phosphate in Lung Fibrosis
BS Shea, AM Tager
Proceedings of the American Thoracic Society 2012
PAI-1 in Tissue Fibrosis
AK Ghosh, DE Vaughan
Journal of Cellular Physiology 2012
Coagulation Cascade Proteinases in Lung Injury and Fibrosis
RC Chambers, CJ Scotton
Proceedings of the American Thoracic Society 2012
Matrix Proteases in Health and Disease: BEHRENDT:MATRIX PROTEASES O-BK
F Werner, K Sachse, T Reinheckel
Matrix Proteases in Health and Disease: BEHRENDT:MATRIX PROTEASES O-BK 2012
The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice
AJ Courey, JC Horowitz, KK Kim, TJ Koh, ML Novak, N Subbotina, M Warnock, B Xue, AK Cunningham, Y Lin, MP Goldklang, RH Simon, DA Lawrence, TH Sisson
Blood 2011
Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis
I Sörensen, N Susnik, T Inhester, JL Degen, A Melk, H Haller, R Schmitt
Kidney International 2011
Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus-Based Immunosuppression : Limiting HCV with Sirolimus
GJ McKenna, JF Trotter, E Klintmalm, N Onaca, R Ruiz, LW Jennings, M Neri, JG O’Leary, GL Davis, MF Levy, RM Goldstein, GB Klintmalm
American Journal of Transplantation 2011
Effect of the plasminogen-plasmin system on hypertensive renal and cardiac damage
B Knier, N Cordasic, B Klanke, J Heusinger-Ribeiro, C Daniel, R Veelken, A Hartner, KF Hilgers
Journal of Hypertension 2011
Treatment with imatinib results in reduced IL-4-producing T cells, but increased CD4(+) T cells in the broncho-alveolar lavage of patients with systemic sclerosis
AA Divekar, D Khanna, F Abtin, P Maranian, R Saggar, R Saggar, DE Furst, RR Singh
Clinical immunology (Orlando, Fla.) 2011
NRF2 deficiency reduces life span of mice administered thoracic irradiation
EL Travis, G Rachakonda, X Zhou, K Korhonen, KR Sekhar, S Biswas, ML Freeman
Free radical biology & medicine 2011
Prostaglandin E2 and the Pathogenesis of Pulmonary Fibrosis
PD Bozyk, BB Moore
American journal of respiratory cell and molecular biology 2011
Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling
TP Vacek, JC Vacek, SC Tyagi
Archives Of Physiology And Biochemistry 2011
Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis
M Wygrecka, G Kwapiszewska, E Jablonska, S Gerlach, I Henneke, D Zakrzewicz, A Guenther, KT Preissner, P Markart
American journal of respiratory and critical care medicine 2011
Effects of Pharmacological Inhibition and Genetic Deficiency of Plasminogen Activator Inhibitor-1 in Radiation-Induced Intestinal Injury
R Abderrahmani, A François, V Buard, M Benderitter, JC Sabourin, DL Crandall, F Milliat
International Journal of Radiation Oncology*Biology*Physics 2009
Fibrinolysis-independent role of plasmin and its activators in the haematopoietic recovery after myeloablation
M Tjwa, R Moura, L Moons, S Plaisance, MD Mol, S Jansen, M Dewerchin, C Verfaillie, P Carmeliet
Journal of Cellular and Molecular Medicine 2009
Pulmonary epithelium is a prominent source of proteinase-activated receptor-1-inducible CCL2 in pulmonary fibrosis
PF Mercer, RH Johns, CJ Scotton, MA Krupiczojc, M Königshoff, DC Howell, RJ McAnulty, A Das, AJ Thorley, TD Tetley, O Eickelberg, RC Chambers
American journal of respiratory and critical care medicine 2008
The role of urokinase in idiopathic pulmonary fibrosis and implication for therapy
M Gharaee-Kermani, B Hu, SH Phan, MR Gyetko
Expert Opinion on Investigational Drugs 2008
The Absence of uPAR Is Associated with the Progression of Dermal Fibrosis
Y Kanno, A Kaneiwa, M Minamida, M Kanno, K Tomogane, K Takeuchi, K Okada, S Ueshima, O Matsuo, H Matsuno
Journal of Investigative Dermatology 2008
Advances in mechanisms of repair and remodelling in acute lung injury
CC Dos Santos
Intensive Care Medicine 2008
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy
P Pontrelli, M Rossini, B Infante, G Stallone, A Schena, A Loverre, M Ursi, R Verrienti, A Maiorano, G Zaza, E Ranieri, L Gesualdo, P Ditonno, C Bettocchi, FP Schena, G Grandaliano
Transplantation 2008
Suppressor of cytokine signaling 1 inhibits pulmonary inflammation and fibrosis
T Nakashima, A Yokoyama, Y Onari, H Shoda, Y Haruta, N Hattori, T Naka, N Kohno
Journal of Allergy and Clinical Immunology 2008
Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients
K Kowal, S Żukowski, M Moniuszko, A Bodzenta-Łukaszyk
Folia Histochemica et Cytobiologica 2008

Advertisement
Advertisement